Hims vs LifeMD: Comparing Two GLP-1 Telehealth Models

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

A PlexusDx Education Hub comparison covering GLP-1 therapies, weight management protocols, and the genetics underneath every metabolic decision. Browse all Peptides & GLP-1 education.

This is an independent editorial comparison. PlexusDx has no commercial relationship with Hims or its parent company, and no affiliate links or compensation are involved. Hims and LifeMD are two of many GLP-1 telehealth options as of April 2026; this piece focuses on the two brands named in the query.

Two routes to the same GLP-1 pharmacology

Hims, part of Hims & Hers Health, is a consumer telehealth brand with a broad direct-to-consumer footprint, and LifeMD is a subscription-telehealth service. Both offer GLP-1 weight management, and both publish current program details and pricing on their own sites - Hims's official website and LifeMD's official website.

What Hims includes in its weight program

A program in the Hims model generally combines a virtual clinical evaluation with provider-issued prescriptions, dispensing either brand-name FDA-approved GLP-1 products or compounded semaglutide and tirzepatide through licensed compounding-pharmacy pathways. The polished consumer onboarding is a selling point, but the clinical steps track the wider category.

How the enrollment feels

Intake, clinician review, prescription, and follow-up remain the backbone. The recognizable brand shapes the experience and marketing more than the medicine itself.

What LifeMD includes in its weight program

LifeMD wraps evaluation, prescribing, and follow-up into a recurring subscription, with medication options and dispensing pathways that vary by plan. As with Hims, provider type, pharmacy partner, and billing cadence differ by program and should be verified at the source before enrolling.

Comparing beyond the brand name

When two programs offer the same class of medication, the meaningful comparison shifts to service details: how quickly you reach a provider, how dose titration is handled, what happens if you experience side effects, and how billing is structured. Hims emphasizes a streamlined consumer experience, while LifeMD centers an ongoing subscription relationship. Neither positioning changes the compound you receive, so weigh the support model and total cost alongside the brand you recognize before deciding which fits your situation.

Confirming price before you commit

GLP-1 telehealth pricing varies widely as of April 2026, with typical monthly totals spanning roughly $200 to $700-plus after program fees, medication, and compounded-pharmacy dispensing. Specific pricing for Hims and LifeMD is published on each brand's own site. Rather than quote numbers that may be stale, confirm current pricing directly on each brand's pricing page before any purchase decision.

Why the brand on the box doesn't change the mechanism

The active pharmacology is identical no matter which brand delivers it. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) act on satiety signaling, appetite regulation, and gastric emptying. The evidence base - STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024) - reflects the compounds, with effect sizes varying by compound, dose, and population.

Genetics: the missing input on both intake forms

Neither Hims nor LifeMD reads the genetics that shape a GLP-1 response. Variants in GLP1R (the GLP-1 receptor gene targeted by every GLP-1 compound), FTO, MC4R, and TCF7L2 describe the metabolic terrain a clinician prescribes into. These pathway-level signals do not predict response to any specific compound, but they add context a branded intake form omits. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols - Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before starting, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, the test-before-you-invest step toward an informed conversation with your provider.

Not affiliated: PlexusDx is not affiliated with Hims and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: What Is GLP-1, GLP-1 What Is, GLP-1 Receptor Agonist, GLP-1 Drugs.

Frequently Asked Questions

Is Hims or LifeMD better for GLP-1 weight loss?

Neither is objectively better; both run GLP-1 telehealth programs with comparable clinical structures. Differences show up in medication options, pricing tiers, brand experience, and provider model. The right fit depends on cost, coverage, and program mechanics, so review each brand's own details before committing.

How do Hims and LifeMD differ on medication?

Each brand can prescribe GLP-1 receptor agonists via telehealth. The differences sit in dispensing pathway (FDA-approved brand versus compounded), subscription structure, and provider type. Neither platform alters the underlying pharmacology, which is set by the compound itself rather than the brand delivering it to your door.

Can the Precision Peptide Genetic Test tell me which program will work?

No. It forecasts response to no compound and no telehealth program. It reports pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 biology, upstream context that stays relevant regardless of whether you choose Hims, LifeMD, or another brand.

How does PlexusDx compare to Hims and LifeMD?

PlexusDx pairs its Weight Management Protocols with the Precision Peptide Genetic Test for upstream genetic context. The differentiator is pathway-level insight mapping FTO, MC4R variants, context not offered at Hims, LifeMD, or most other GLP-1 telehealth programs alongside the medication itself.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.